Streetbeat News

Products Services

SXTP

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) will present a scientific poster on the long-term safety data of tafenoquine for malaria prevention at the ILADS 2023 annual scientific meeting. The company will also review the use of 8-aminoquinolines in treating malaria and babesiosis. Tafenoquine is approved for malaria prophylaxis in the US under the product name ARAKODA®. However, it has not been proven effective for treatment or prevention of babesiosis and is not FDA approved for such indications.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 12:42 pm

SWAV

Shockwave Medical, Inc. (NASDAQ:SWAV) announced that two new publications reported excellent and consistent outcomes with coronary intravascular lithotripsy (IVL) in both nodular and eccentric calcium. The publications reported separate patient-level pooled optical coherence tomography (OCT) sub-analyses of the company-sponsored Disrupt CAD clinical studies. The results showed that IVL was highly effective in modifying the calcium prior stent implantation, reducing stenosis to a residual area of less than 15 percent with an acute gain of 1.8 mm2 in a safe manner with no major procedural complications.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 12:39 pm

IPX

IperionX Limited (NASDAQ:IPX) has received a Letter of Interest from the Export-Import Bank of the United States (EXIM Bank) for a provisional sum of $11.5 million in equipment finance for the development of its Titanium Production Facility in Virginia. The funding will be used for key production assets including industrial furnaces and comminution equipment. The facility is expected to start production in 2024 and will be scaled to produce 1,125 metric tons of titanium per annum.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:37 pm

MAIA

MAIA Biotechnology will present preliminary safety and efficacy data from the THIO-101 Phase 2 clinical trial at the European Society for Medical Oncology Congress in 2023.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:36 pm

VRAR

Sector 5 Digital (S5D), a subsidiary of The Glimpse Group, Inc. (NASDAQ:VRAR), has entered into a six-figure engagement with one of the world's largest architecture firms. The project involves using Augmented Reality (AR) to visualize the new business campus of a multinational retail company. The AR offering includes various 'lenses' for viewing the campus in WebAR, which can be accessed via a browser without requiring an app download.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:35 pm

TMO

Thermo Fisher Scientific has announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim to develop CDx tests for identifying patients with non-small cell lung cancer (NSCLC) with specific genomic mutations. The collaboration will leverage the Oncomine Dx Express Test and the Oncomine Dx Target Test. The aim is to improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:35 pm

JAGX

An independent study conducted at Boston Children's Hospital and Harvard Medical School has shown potential utility of Jaguar Health's drug, Crofelemer, for the treatment of MVID, a rare childhood disease. Currently, there are no approved drug treatments for MVID. Crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for MVID, and Jaguar Health's Investigational New Drug application for crofelemer for treatment of MVID is now activated by the FDA.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:34 pm

BKTI

BK Technologies Corporation (NYSE:BKTI) has shipped its BKR 9000 multiband radios to the Hawaii Department of Health, Emergency Medical Services & Injury Prevention System Branch. The purchase was made in response to the Maui wildfires and as part of the state's lifecycle replacement program. The radios will be used for inter-agency and intra-agency portable communications.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:34 pm

PCVX

Vaxcyte has announced that the FDA has cleared its Investigational New Drug application for VAX-31, a drug aimed at preventing invasive pneumococcal disease in adults.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:32 pm

STLA

Stellantis NV has integrated ChatGPT into DS Automobiles. The system has been given to the first 20,000 registered users with DS Iris System on DS 3/DS 4/DS 7/DS 9. The integration is in a pilot phase within Stellantis for 6 months.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:26 pm